Shahrad Hakimian is a Gastroenterology physician affiliated with University of California, Los Angeles. OpenAlex indexes 40 publications with 803 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8536 Wilshire Blvd Ste 102
Beverly Hills, CA 902113154
Telephone
310-248-8200Provider last certified this registry record 14 Oct 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20252 payments
- ABBVIE INC.Program year20253 payments
- GENZYME CORPORATIONProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Proton pump inhibitor37.4%Omeprazole74%Pantoprazole Sodium26%Part D<11 patientsGuanylate Cyclase-C Agonist26.7%Linzess100%Part D≥23 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Managing Pouchitis: Where do Antibiotics End, and Advanced Therapies Begin?
Current Gastroenterology Reports
2025 - S1598 Efficacy of Transoral Outlet Reduction for Weight Regain Following Roux-en Y Gastric Bypass: A Comparison of Pre and Post COVID-19 Pandemic
The American Journal of Gastroenterology
2024 - Recent trends and risk factors associated with <i>Clostridioides difficile</i> infections in hospitalized patients with inflammatory bowel disease
Alimentary Pharmacology & Therapeutics
2023 - S1086 The Impact of Intravenous Corticosteroid Therapy in Hospitalized Patients With Inflammatory Bowel Disease with Clostridioides difficile Infection
The American Journal of Gastroenterology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”